P/E ratio for Aspen Pharmacare (APN.JO)
P/E ratio at the end of 2021: 12.9
According to Aspen Pharmacare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 10.2415. At the end of 2021 the company had a P/E ratio of 12.9.
P/E ratio history for Aspen Pharmacare from 2003 to 2021
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 12.9 | -10.96% |
| 2020 | 14.5 | 134.93% |
| 2019 | 6.17 | -61.32% |
| 2018 | 16.0 | -17.17% |
| 2017 | 19.3 | -42.29% |
| 2016 | 33.4 | 42.3% |
| 2015 | 23.5 | 40.9% |
| 2014 | 16.6 | -2.31% |
| 2013 | 17.0 | 80.85% |
| 2012 | 9.42 | 66.09% |
| 2011 | 5.67 | -19.21% |
| 2010 | 7.02 | 2.39% |
| 2009 | 6.86 | 9.39% |
| 2008 | 6.27 | -15.51% |
| 2007 | 7.42 | -8.19% |
| 2006 | 8.08 | 23.7% |
| 2005 | 6.53 | 40.75% |
| 2004 | 4.64 | 22.56% |
| 2003 | 3.79 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.